News

Evgen Pharma PLC - Notice of Results

EVG · EVG23 Nov 2021

RNS Number: 1731 T Evgen Pharma PLC 23 November 2021 Evgen Pharma plc. Evgen Pharma plc, a clinical stage drug development company developing sulforaphane based medicines for the treatment of multiple diseases, announces it will issue its unaudited interim results for the six months ended 30 September 2021 on Tuesday, 7 December 2021.. The has its headquarters...

h2{margin-right:0cm;margin-left:0cm;font-size:18.0pt;font-family:"Times New Roman","serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue }visited{ color: #954F72 } ...

Share